Eye Care’s Role in the Evolving Managed Care Market

Eye Care’s Role in the Evolving Managed Care Market

Recently, our practice has seen an uptick in referrals from primary care physicians (PCPs) who are advising their senior patients to be screened for glaucoma and their patients with diabetes to undergo a retinal exam. This is undoubtedly in response to the provision of the Affordable Care Act (ACA) that enables CMS to increase or decrease payments to Medicare Advantage Plans based on their Medicare Health Plan Quality and Performance Ratings, i.e. their Star Ratings. The plans in turn must ensure their participating providers are mindful of the Star Ratings components, two of which are eyecare-related HEDIS measures. The Glaucoma Screening in Older Adults (GSO) measure tracks the percentage of plan members age 65 and older who receive an eye exam for early identification of glaucomatous conditions. The Comprehensive Diabetes Care (CDC) measure tracks the percentage of plan members age 18-75 who have diabetes who undergo a list of tests, including a retinal exam.

As additional aspects of the ACA click into place, we can expect this type of referral to increse even more. Health insurance exchanges, for example, will encompass different types of managed care plans aimed at the general populations that are government-funded or subsidized and likely subject to Star Ratings or similar quality measures. These dynamics offer ophthalmology and optometry practices the opportunity to develop referral patterns with the primary care physician in our communities. Whether or not patients have been referred to our offices by their primary care doctors, we can identify those to whom the quality measures pertain, provide the relevent services and inform the doctors of the tests and results. We gain a marketing tool, while our patients benefit from the preventative care.

From The Blog

Upcoming Clinical Education

August 16, 2017

Thursday, October 26th from 6:00 pm to 8:30 pm Co-Managing Cataract, MIGS and Laser Refractive Surgery  by: Aaron Amacher III, MD Managing the Reluctant Glaucoma Patient  by: Andrew Rabinowitz, MD Location: Desert Willow Conference Center. 4340 E. Cotton Center Blvd., Phoenix, AZ 85040 Seating is Limited Register Today

Welcome Mahmood El Gasim, MD

July 28, 2017

Please help us Welcome Dr. Mahmood El Gasim, MD, Retina and Uveitis Surgeon to Barnet Dulaney Perkins Eye Center! Mahmood El Gasim, MD, specializes in diseases and treatment of the retina and vitreous and treatment of uveitis, inflammatory eye conditions that can be associated with underlying systemic disease. Dr. El Gasim attended Duke University, where he received the Angier B.

Learn More

Trimoxi During Cataract Surgery

March 29, 2017

Trimoxi is a medication that is injected into the eye at the time of cataract surgery. It is a compounded injection that consists of Triamcinolone and Moxifloxacin. The surgeon will inject the Trimoxi through the pars plana into the vitreous. A trial ad already been done with Trimoxi and we were happy with the results and the added benefits to

Learn More

Best Wishes to Robert Fintelmann, MD

September 21, 2016

Over the past several years, Dr. Robert Fintelmann has been an integral part of Barnet Dulaney Perkins Eye Center, and we are grateful for the service he has provided our patients. It is with deep regret that we announce Dr. Fintelmann has left the practice as of September 9, 2016. He has enjoyed caring for your patients over the years

Learn More

Attend our Upcoming Clinical Education Courses

November 3, 2015

Tuesday, November 10th from 6:00pm to 8:00pm Neurosurgery, Brain Tumors, and Vision, by Dr. Andrew Little, Co-Director, Barrow Pituitary Center New Approaches to the Treatment of Exudative Macular Degeneration, by Jack Sipperley, MD Location: Wrigley Mansion, 2501 E. Telewa Trail, Phoenix, AZ 85016 2.0 Hours of COPE Approved Continuing Education (pending) Register Today Tuesday, December 1st from 6:00pm to 8:00pm Post-Operative

Learn More

View All Doctor Portal Posts >>